Stem cell in alternative treatments for brain tumors: potential for gene delivery

Despite ongoing research efforts and attempts to bring new drugs into trial, the prognosis for brain tumors remains poor. Patients with the most common and lethal intracranial neoplasia, glioblastoma multiforme (GBM), have an average survival of one year with combination of surgical resection, radio...

Descripción completa

Detalles Bibliográficos
Autores principales: Mariotti, Veronica, Greco, Steven J, Mohan, Ryan D, Nahas, George R, Rameshwar, Pranela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451968/
https://www.ncbi.nlm.nih.gov/pubmed/26056591
http://dx.doi.org/10.1186/2052-8426-2-24

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451968/
https://www.ncbi.nlm.nih.gov/pubmed/26056591
http://dx.doi.org/10.1186/2052-8426-2-24

Ejemplares similares